Henan Taloph Pharmaceutical Stock Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Henan Taloph Pharmaceutical Stock Company Limited with three other
companies in this sector in China:
Chongqing Lummy Pharmaceutical Co Ltd
sales of 963.85 million Chinese Renmimbi [US$140.93 million]
of which 94%
was Chemical Manufacturing),
Betta Pharmaceuticals Co Ltd
(914.60 million Chinese Renmimbi [US$133.73 million]
Zhejiang Shapuaisi Pharmaceutical Co Ltd
(921.67 million Chinese Renmimbi [US$134.77 million]
of which 100%
Henan Taloph Pharmaceutical Stock Company Limited reported sales of 1.02 billion Chinese Renmimbi (US$148.74 million)
December of 2015.
decrease of 18.9%
versus 2014, when the company's sales were 1.25 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 73.0% decline
in Other, from 13.77 million Chinese Renmimbi to 3.72 million Chinese Renmimbi.
There were also decreases in sales in
Medicine Manufacturing (down 56.2% to 341.83 million Chinese Renmimbi)
However, these declines were partially offset by the increase in sales of
Medicine Distribute (up 30.5% to 600.03 million Chinese Renmimbi)